Literature DB >> 1653835

Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery.

M Mimeault1, A Fournier, Y Dumont, S St-Pierre, R Quirion.   

Abstract

Recent data have suggested that N-truncated human calcitonin gene-related peptide (hCGRP) fragments such as hCGRP8-37 and hCGRP12-37 behave as competitive antagonists in certain bioassays. The present study was undertaken to determine which amino acid residues between positions 8 to 12 are directly involved in ensuring high affinity and antagonist properties at CGRP receptors. In brain, atrium and vas deferens membrane preparations, hCGRP8-37 and hCGRP9-37 demonstrated affinities similar to or much higher than that of the native peptide hCGRP alpha. Shorter fragments such as hCGRP 10-37 and hCGRP 11-37 possessed less than 20% of the affinity of hCGRP alpha in these various assays demonstrating the critical importance of the Thr residue in position 9 for maintenance of adequate receptor affinity. In the in vitro guinea pig left and right atria bioassays, both hCGRP8-37 and hCGRP9-37 behaved as potent and competitive antagonists (pA2:7.0-7.7) of positive chronotropic and inotropic effects induced by hCGRP alpha. hCGRP 10-37 and hCGRP 11-37 were at least 10 times less potent (pA2: 6.1-6.6). Interestingly, both hCGRP 8-37 and hCGRP9-37 were much less potent (pA2: 6.2-6.3) in blocking the effects of hCGRP alpha in the rat vas deferens whereas only slight inhibition was observed at 1.0 microM with hCGRP10-37 and no blocking activity was detected with hCGRP11-37 at a low micromolar concentration. These results are in accordance with binding data and demonstrate further the importance of residues in positions 9 (Thr) and 10 (His) to ensure potent antagonistic properties of N-truncated hCGRP fragments.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653835

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Receptors mediating CGRP-induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by h(alpha) CGRP(8-37).

Authors:  F M Wisskirchen; D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  CGRP(2) receptor in the internal anal sphincter of the rat: implications for CGRP receptor classification.

Authors:  F M Wisskirchen; I Marshall
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Conformational restraints revealing bioactive beta-bend structures for halpha CGRP8-37 at the CGRP2 receptor of the rat prostatic vas deferens.

Authors:  F M Wisskirchen; P M Doyle; S L Gough; C J Harris; I Marshall
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

4.  Multiple receptors for calcitonin gene-related peptide and amylin on guinea-pig ileum and vas deferens.

Authors:  A E Tomlinson; D R Poyner
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 5.  Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.

Authors:  L Edvinsson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Peptidergic modulation of synaptic transmission in the parabrachial nucleus in vitro: importance of degradative enzymes in regulating synaptic efficacy.

Authors:  T M Saleh; S B Kombian; J A Zidichouski; Q J Pittman
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

7.  Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations.

Authors:  S Giuliani; S J Wimalawansa; C A Maggi
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  The role of the 8-18 helix of CGRP8-37 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions.

Authors:  Stephen G Howitt; Kalle Kilk; Yang Wang; David M Smith; Ulo Langel; David R Poyner
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

9.  Adrenomedullin-2/intermedin induces cAMP accumulation in dissociated rat spinal cord cells: evidence for the existence of a distinct class of sites of action.

Authors:  Ali Akbar Owji; Jean-Guy Chabot; Yvan Dumont; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2008-04-17       Impact factor: 3.444

10.  Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin.

Authors:  A M Elhawary; J Poon; C C Pang
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.